Covered recipient · General Payments record
STACY LEE PARKER BYONE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$38,298.10
- Reported across 216 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,900.00 | 2 |
| Food and Beverage | $2,339.28 | 54 |
| Travel and Lodging | $2,234.18 | 5 |
| Consulting Fee | $351.25 | 1 |
| Education | $95.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $6,392.18 | 9 |
| Merck Sharp & Dohme Corporation | $428.99 | 13 |
| E.R. Squibb & Sons, L.L.C. | $369.22 | 4 |
| Janssen Biotech, Inc. | $336.52 | 9 |
| JAZZ PHARMACEUTICALS INC. | $182.96 | 2 |
| PUMA BIOTECHNOLOGY, INC. | $124.59 | 2 |
| ABBVIE INC. | $121.06 | 5 |
| Rigel Pharmaceuticals, Inc. | $120.19 | 1 |
| Acerta Pharma LLC | $120.12 | 1 |
| Incyte Corporation | $118.73 | 2 |
| Gilead Sciences, Inc. | $118.48 | 1 |
| Genentech USA, Inc. | $109.54 | 4 |
| Agios Pharmaceuticals, Inc. | $93.20 | 1 |
| Tempus AI, Inc | $89.25 | 1 |
| Celgene Corporation | $58.54 | 2 |
| Daiichi Sankyo Inc. | $38.04 | 1 |
| Lilly USA, LLC | $24.33 | 1 |
| Genmab U.S., Inc. | $21.66 | 1 |
| Paratek Pharmaceuticals, Inc. | $21.31 | 1 |
| Cumberland Pharmaceuticals, Inc. | $17.10 | 1 |
| GENZYME CORPORATION | $13.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (63)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.